fosinopril has been researched along with Disease Exacerbation in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, R; Li, G; Li, X; Wen, Y; Yue, C | 1 |
| Agrawal, A; Dubey, GP; Ghosh, B; Rajak, M; Singh, RG | 1 |
| An, SJ; Choi, JH; Choi, KD; Kim, HJ; Kim, JS; Lee, JE | 1 |
| Deng, JL; Hou, YB; Li, J; Wang, H; Yue, J | 1 |
| Ao, X; Peng, WS; Tang, R; Tang, TF; Veeraragoo, P; Zhou, QL | 1 |
| Lan, H; Li, P; Liang, Q; Lu, J; Luo, G; Wang, Y; Yin, T; Zhang, H; Zhang, X; Zhao, T | 1 |
| Bovee, KC; Buranakarl, C; Chaiyabutr, N; Kanchanapangka, S; Kitjtawonrat, A; Pondeenana, S; Sunyasujaree, B | 1 |
| Baggio, G; Bond, MG; Crepaldi, G; Gallus, G; Magni, A; Mancia, G; Rubba, P; Sampieri, L; Sperti, G; Veglia, F; Ventura, A; Zanchetti, A | 1 |
| Chan, JC; Chan, WB; Chow, CC; Cockram, CS; Ko, GT; Lee, KF; Lo, MK; Ma, RC; Ozaki, R; So, WY; Tong, PC | 1 |
| Comi, LI; De Luca, F; Nigro, G; Palladino, A; Passamano, L; Politano, L | 1 |
| García-Robles, R; Rábano, A; Ruilope, LM; Villa, E | 1 |
| Deedwania, PC | 1 |
| Baggio, G; Bond, MG; Collatina, S; Crepaldi, G; Gallus, GV; Mancia, G; Rubba, P; Sampieri, L; Serrotti, E; Veglia, F; Ventura, A; Zanchetti, A | 1 |
2 review(s) available for fosinopril and Disease Exacerbation
| Article | Year |
|---|---|
Prostaglandin E1 for preventing the progression of diabetic kidney disease.
Topics: Albuminuria; Alprostadil; Diabetic Nephropathies; Disease Progression; Drugs, Chinese Herbal; Fosinopril; Humans; Losartan; Proteinuria; Randomized Controlled Trials as Topic; Vasodilator Agents | 2010 |
The progression from hypertension to heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Disease Progression; Female; Fosinopril; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Middle Aged | 1997 |
4 trial(s) available for fosinopril and Disease Exacerbation
| Article | Year |
|---|---|
Comparative evaluation of fosinopril and herbal drug Dioscorea bulbifera in patients of diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Diabetic Nephropathies; Dioscorea; Disease Progression; Female; Fosinopril; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phytotherapy; Plant Extracts; Prospective Studies; Proteinuria | 2013 |
Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Carotid Stenosis; Disease Progression; Diuretics; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pravastatin; Sodium Chloride Symporter Inhibitors | 2004 |
The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fosinopril; Humans; Kidney Failure, Chronic; Male; Middle Aged; Treatment Outcome | 2006 |
Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lo
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carotid Arteries; Cholesterol; Disease Progression; Drug Therapy, Combination; Female; Fosinopril; Heart Rate; Humans; Hypercholesterolemia; Hypertension; Italy; Male; Middle Aged; Pravastatin; Systole; Tunica Intima; Ultrasonography | 2001 |
7 other study(ies) available for fosinopril and Disease Exacerbation
| Article | Year |
|---|---|
Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Antiphospholipid; Biopsy; Chi-Square Distribution; Disease Progression; Female; Follow-Up Studies; Fosinopril; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Logistic Models; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Proportional Hazards Models; Proteinuria; Renin-Angiotensin System; Risk Factors; Statistics, Nonparametric; Treatment Outcome; Young Adult | 2018 |
Simultaneous posterior ischemic optic neuropathy, cerebral border zone infarction, and spinal cord infarction after correction of malignant hypertension.
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Brain; Brain Stem Infarctions; Cerebral Infarction; Disease Progression; Female; Fosinopril; Humans; Hydralazine; Hypertension, Malignant; Hypotension; Iatrogenic Disease; Magnetic Resonance Imaging; Nifedipine; Optic Neuropathy, Ischemic; Paraparesis; Spinal Cord; Spinal Cord Ischemia; Tetrazoles; Urinary Incontinence; Vision, Low | 2008 |
Fosinopril and losartan regulate klotho gene and nicotinamide adenine dinucleotide phosphate oxidase expression in kidneys of spontaneously hypertensive rats.
Topics: Animals; Disease Progression; Fosinopril; Gene Expression Regulation, Enzymologic; Glucuronidase; Hypertension; Kidney; Klotho Proteins; Losartan; Male; NADPH Oxidases; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger | 2011 |
Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Fosinopril; Gas Chromatography-Mass Spectrometry; Humans; Hypertrophy; Kidney Cortex; Male; Metabolomics; Proteinuria; Rats; Rats, Wistar; Toxins, Biological | 2012 |
Comparison of dipyridamole and fosinopril on renal progression in nephrectomized rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Dipyridamole; Disease Progression; Fosinopril; Male; Nephrectomy; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Renal Insufficiency | 2003 |
Cardiac treatment in neuro-muscular diseases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Cardiac Output, Low; Case-Control Studies; Disease Progression; Fosinopril; Furosemide; Humans; Muscular Dystrophies, Limb-Girdle; Muscular Dystrophy, Duchenne; Myotonic Dystrophy; Pregnenediones; Prognosis; Retrospective Studies; Severity of Illness Index; Sodium Potassium Chloride Symporter Inhibitors | 2006 |
Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy.
Topics: Albuminuria; Animals; Antihypertensive Agents; Antineoplastic Agents; Blood Glucose; Blood Pressure; Body Weight; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Epoprostenol; Fosinopril; Kidney Glomerulus; Male; Multivariate Analysis; Rats; Rats, Wistar | 1997 |